Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
154M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
30.4M
-
Shares change
-
+10.3M
-
Total reported value, excl. options
-
$531M
-
Value change
-
+$191M
-
Put/Call ratio
-
0.48
-
Number of buys
-
60
-
Number of sells
-
-15
-
Price
-
$17.49
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2021
90 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q4 2021.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.4M shares
of 154M outstanding shares and own 19.75% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (7.45M shares), Avidity Partners Management LP (3.03M shares), RTW INVESTMENTS, LP (3.02M shares), Abingworth LLP (2.12M shares), Polar Capital Holdings Plc (1.53M shares), BlackRock Inc. (1.45M shares), VANGUARD GROUP INC (1.25M shares), Point72 Asset Management, L.P. (804K shares), Cormorant Asset Management, LP (750K shares), and DAFNA Capital Management LLC (733K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.